Arcus Biosciences, Inc. (RCUS) vs Vericel Corporation (VCEL)

• Arcus Biosciences, Inc. RCUS 18.28 ▲ +3.34%
• Vericel Corporation VCEL 54.62 ▲ +5.48%

Arcus Biosciences, Inc. and Vericel Corporation are both Biotechnology companies. Arcus Biosciences, Inc. and Vericel Corporation are of similar size ($2.7B and $2.5B). Arcus Biosciences, Inc. has negative trailing earnings, so its P/E is not meaningful; Vericel Corporation trades at 82.9×. Vericel Corporation grew revenue faster over the last twelve months: 25.3% against −58.3%. Vericel Corporation has the higher net margin (10.3% vs −453.0%) and the higher return on invested capital (7.88% vs 0.00%). Across the 19 metrics below, Vericel Corporation leads on 16 and Arcus Biosciences, Inc. on 3.